Bortezomib‐Encapsulated Dual Responsive Copolymeric Nanoparticles for Gallbladder Cancer Targeted Therapy

Gallbladder cancer (GBC) is a rare but the most malignant type of biliary tract tumor. It is usually diagnosed at an advanced stage and conventional treatments are unsatisfactory. As a proteasome inhibitor, bortezomib (BTZ) exhibits excellent antitumor ability in GBC. However, the long‐term treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mingyu, Juengpanich, Sarun, Li, Shijie, Topatana, Win, Lu, Ziyi, Zheng, Qiang, Cao, Jiasheng, Hu, Jiahao, Chan, Esther, Hou, Lidan, Chen, Jiang, Chen, Fang, Liu, Yu, Jiansirisomboon, Sukanda, Gu, Zhen, Tongpeng, Suparat, Cai, Xiujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895115/
https://www.ncbi.nlm.nih.gov/pubmed/35068071
http://dx.doi.org/10.1002/advs.202103895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895115/
https://www.ncbi.nlm.nih.gov/pubmed/35068071
http://dx.doi.org/10.1002/advs.202103895

Ejemplares similares